The 580,000-square-meter supermall, scheduled to open this winter, will bring in Michelin restaurants and bars, Sheraton Hotel and other famous brands.
So far, Akesobio has successfully developed more than 30 innovative drug candidates for oncology, autoimmunity, inflammation, metabolic disease and other major diseases.
